J Exp Clin Cancer Res 2012, 31:60. (19 July 2012)jmnPubMedCrossRef 22. Mosmann TJ: Rapid colorimetric assay for cellular Cilengitide manufacturer growth and survival: application to proliferation and cytotoxicity assays. Immunol. Methods 1983, 65:55–63.CrossRef 23. Rothe G, Valet GJ: Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. Leukoc Biol. 1990, 47:440–448. 24. Pourquier P, Ueng LM, Fertala
J, Wang D, Park HK, Essigmann JM, Bjornsti Vactosertib solubility dmso MA, Pommier Y: Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine. Biol Chem 1999, 274:8516–8523.CrossRef 25. Binaschi M, Farinosi R, Borgnetto ME, Capranico G: In vivo site specificity and human isoenzyme selectivity of two topoisomerase II-poisoning anthracyclines. Cancer Res 2000, 60:3770–3776.PubMed 26. Vitale G, Zappavigna S, Marra M, Dicitore A, Meschini S, Condello M, Arancia G, Castiglioni S, Maroni P, Bendinelli P, Piccoletti R, Van Koetsveld PM, Cavagnini F, Budillon A, Abbruzzese A, Hofland LJ, Caraglia M: The PPAR-#agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-# treated pancreatic cancer cells. Biotechnol Adv 2012,30(1):169–184.PubMedCrossRef 27. Vitale G, Van Eijck CH, Van Koetsveld Ing PM, Erdmann JI, Speel
EJ, van der Wansem
Ing K, Mooij DM, Colao A, Lombardi G, Croze E, Lamberts SW, Hofland LJ: Type I interferons in the treatment of Smoothened Agonist supplier pancreatic cancer: mechanisms of action and role of related receptors. Ann Surg 2007,246(2):259–268.PubMedCrossRef 28. Perego P, Capranico G, Supino R, Zunino F: Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types. AnticancerDrugs 1994, 5:645–649.CrossRef 29. Gutierrez PL: The metabolism of quinone-containing alkylating agents: free radical production and measurement. Front Biosci 2000, 5:629–638.CrossRef 30. Dandawate PR, Vyas AC, Padhye SB, Singh MW, Baruah JB: Perspectives on medicinal properties of benzoquinone compounds. Mini Rev Med Chem 2010, 10:436–454.PubMedCrossRef buy Lonafarnib 31. Riedl SJ, Renatos M, Schwarzenbacher R, Zhou Q, Sun C, Fesik SW, Liddington RC, Salvesen GS: Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001, 104:791–800.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions RF and MC carried out the design of the experiments and drafted the manuscript. CP, MF, AP and MC participated in the experiments of cell culture and molecular biology. JM, AM, AG and GC, participated in statistical analysis and interpretation. ALG and MDR participated in the design of the experiments. All authors read and approved the final manuscript.